MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-14-2024
Motus GI Holdings EBITDA per Share 2011-2026 | MOTS
Annual EBITDA per Share Motus GI Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.41 | -55.9 | -7.24 | -0.582 | -0.924 | -1.24 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.582 | -55.9 | -12.2 |
Quarterly EBITDA per Share Motus GI Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.37 | - | -4.3 | -0.48 | -0.89 | - | -1.51 | -1.61 | -0.08 | - | -0.09 | -0.09 | -0.1 | - | -0.12 | -0.14 | -0.23 | - | -0.19 | -0.26 | -0.29 | - | -0.32 | -0.26 | -0.31 | - | -0.38 | -0.24 | -0.27 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.08 | -4.3 | -0.57 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 111.7 | -1.36 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 19.13 | 1.32 % | $ 555 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 15.7 | -3.03 % | $ 475 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 142.54 | -0.49 % | $ 22.7 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 415.27 | -0.93 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.58 | -1.1 % | $ 332 M | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 18.62 | -1.64 % | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 150.85 | -5.3 % | $ 7.48 B | USA |
 |
Natera
NTRA
|
-5.33 | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 25.23 | -1.06 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
-3.17 | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
-0.87 | $ 6.36 | -5.22 % | $ 568 M | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-2.2 | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 438.34 | -2.2 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.57 | -1.59 % | $ 205 M | Irlanda |
 |
Celcuity
CELC
|
-3.68 | $ 137.68 | 2.2 % | $ 6.44 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 186.61 | -0.71 % | $ 20.7 B | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |